BAM
KRTX

Belpointe Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Belpointe Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-57
Closed -$10.4K – 3601
2023
Q1 		$10.4K Buy
57
+34
+148% +$6.18K ﹤0.01% 2702
2022
Q4 		$4.52K Buy
+23
New +$4.52K ﹤0.01% 2974